Comparative Analysis of Endovascular Treatment and Conventional Medical Management for Vertebrobasilar Artery Occlusion: A Systematic Review and Meta-Analysis - Report - MDSpire
Advertisement
Comparative Analysis of Endovascular Treatment and Conventional Medical Management for Vertebrobasilar Artery Occlusion: A Systematic Review and Meta-Analysis
Clinical Report: Comparative Analysis of Endovascular Treatment for VBAO
Overview
Revise to ensure it accurately reflects the systematic review's findings without overstating benefits.
Background
Acute vertebrobasilar artery occlusion (VBAO) is a critical condition that can lead to high mortality and severe disability. Despite advancements in endovascular therapy (EVT) for anterior circulation strokes, evidence supporting its use in VBAO has been limited. Recent trials have begun to clarify the role of EVT in this context, highlighting the need for comprehensive evaluations of its effectiveness in real-world patient populations.
Data Highlights
Outcome
EVT
Standard Medical Treatment
Odds Ratio (95% CI)
Favorable functional outcome (mRS 0–3)
Higher
Lower
1.92 (1.51–2.43)
Functional independence (mRS 0–2)
Higher
Lower
1.76 (1.39–2.23)
90-day all-cause mortality
Lower
Higher
0.58 (0.49–0.68)
Symptomatic intracranial hemorrhage
Higher
Lower
2.57 (1.31–5.06)
Key Findings
EVT significantly improves favorable functional outcomes (mRS 0–3) compared to standard medical treatment.
Patients receiving EVT have a higher likelihood of achieving functional independence (mRS 0–2).
EVT is associated with a lower risk of 90-day all-cause mortality.
There is an increased risk of symptomatic intracranial hemorrhage with EVT.
Subgroup analyses indicate EVT benefits patients with NIHSS ≥10 and PC-ASPECTS <8.
EVT's effectiveness is less clear in elderly patients and those with mild deficits.
Clinical Implications
The findings support the use of endovascular therapy as a primary treatment for acute VBAO, particularly in patients with significant neurological deficits. Clinicians should weigh the benefits of improved functional outcomes against the risk of symptomatic intracranial hemorrhage when considering EVT for their patients.
Conclusion
Endovascular therapy represents a significant advancement in the management of acute vertebrobasilar artery occlusion, offering improved outcomes despite associated risks. Ongoing evaluation and adherence to emerging guidelines will be essential for optimizing patient care.